Tremendous Potential For Fibromyalgia Pharmaceuticals In Europe With no available therapy for the treatment of fibromyalgia syndrome (FS), pharmaceutical companies have shown great interested in coming up with possible recommendations and therapies for treatment. Central nervous system (CNS) niche disorders have always been a major challenge and FS is no different. Some of the key products in late-stage clinical trials have shown considerable promise and offer high growth opportunities.
Source: www.medicalnewstoday.comResearchers Identify Specific Targets For Pain Therapy - Professor Hanns Ulrich Zeilhofer: "The Challenge Is Now For Pharmaceutical Companies" Researchers in Zurich, Switzerland have identified specific targets for the therapy of patients suffering from chronic pain. In experiments using mice, they succeeded in specifically blocking the relay of pain signals from the spinal cord to the brain. As a result, they were able to restore the body's pain filter in the spinal cord, which ensures that not every sensation, such as light touch, is registered as pain.
Source: www.medicalnewstoday.comLabels: No Prescription, Online Pharmacy
# posted by Network @ 6:01 AM
